These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22740875)

  • 1. Expression of ERα36 in gastric cancer samples and their matched normal tissues.
    Wang J; Li J; Fang R; Xie S; Wang L; Xu C
    Oncol Lett; 2012 Jan; 3(1):172-175. PubMed ID: 22740875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
    Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
    Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.
    Mahboobifard F; Bidari-Zerehpoosh F; Davoudi Z; Panahi M; Dargahi L; Pourgholami MH; Sharifi G; Izadi N; Jorjani M
    Pituitary; 2020 Jun; 23(3):232-245. PubMed ID: 32026205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
    Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells.
    Kim H; Elkins E; Islam R; Cao B; Abbes N; Battles K; Kim S; Kim S; Williams C
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.
    Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H
    BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The elevated level of ERα36 is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma.
    Zhang S; Qiu C; Wang L; Liu Q; Du J
    Steroids; 2014 Sep; 87():39-45. PubMed ID: 24928730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.
    Maczis MA; Maceyka M; Waters MR; Newton J; Singh M; Rigsby MF; Turner TH; Alzubi MA; Harrell JC; Milstien S; Spiegel S
    J Lipid Res; 2018 Dec; 59(12):2297-2307. PubMed ID: 30315000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ERα36 in cell type-specific functions of estrogen and cancer development.
    Mahboobifard F; Dargahi L; Jorjani M; Ramezani Tehrani F; Pourgholami MH
    Pharmacol Res; 2021 Jan; 163():105307. PubMed ID: 33246174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
    Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
    J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
    Zheng Y; Zhang J; Xu ZZ; Sheng JM; Zhang XC; Wang HH; Teng XD; Liu XJ; Cao J; Teng LS
    J Zhejiang Univ Sci B; 2010 Feb; 11(2):144-50. PubMed ID: 20104649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
    Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
    Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of ERα36 in Development and Tumor Malignancy.
    Thiebaut C; Konan HP; Guerquin MJ; Chesnel A; Livera G; Le Romancer M; Dumond H
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression.
    Thiebaut C; Chamard-Jovenin C; Chesnel A; Morel C; Djermoune EH; Boukhobza T; Dumond H
    PLoS One; 2017; 12(3):e0173931. PubMed ID: 28301550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Biological Significance of
    Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression.
    Miceli V; Cocciadiferro L; Fregapane M; Zarcone M; Montalto G; Polito LM; Agostara B; Granata OM; Carruba G
    OMICS; 2011 May; 15(5):313-7. PubMed ID: 21348637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERα36, a variant of estrogen receptor α, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells.
    Yan Y; Yu L; Castro L; Dixon D
    PLoS One; 2017; 12(10):e0186078. PubMed ID: 29020039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRP78 positively regulates estrogen‑stimulated cell growth mediated by ER‑α36 in gastric cancer cells.
    Fu Z; Wang X; Zhou H; Li Y; Chen Y; Wang Z; Liu L
    Mol Med Rep; 2017 Dec; 16(6):8329-8334. PubMed ID: 28983626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
    Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
    Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Role for Estrogen Receptor alpha36 in Cancer Progression.
    Pagano MT; Ortona E; Dupuis ML
    Front Endocrinol (Lausanne); 2020; 11():506. PubMed ID: 32849292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.